Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Print: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2016016084
pages 115-124

Gene Therapy for Lung Cancer

Humberto Lara-Guerra
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Jack A. Roth
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

ABSTRACT

Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.


Articles with similar content:

Autoimmune Etiology in Chronic Prostatitis Syndrome: An Advance in the Understanding of This Pathology
Critical Reviews™ in Immunology, Vol.27, 2007, issue 1
Virginia Elena Rivero, Ruben Dario Motrich, Clelia Maria Riera, Mariana Maccioni
From Molecular Tumor Diagnostics to Individualized Treatment with Phytochemicals Derived from Chinese Herbs
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 4
Thomas Efferth
The Importance of Cancer Stem Cells in Gastrointestinal Cancers
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Duygu Altinok Dindar, Ahmet Ozet, Gulsah Albayrak
Drug Combinations with HDAC Inhibitors in Antitumor Therapy
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2
Noemi Arrighetti, Cristina Corno, Laura Gatti
Optimizing Drug Delivery for Enhancing Therapeutic Efficacy of Recombinant Human Endostatin in Cancer Treatment
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 5
Huanchen Sha, Fuguo Xu, Qingyong Ma